Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Nov 1;5(3):365–373. doi: 10.1158/1940-6207.CAPR-11-0243

Table 2.

Significant Results in Single SNP Analysis Adjusting for Clinical Variables

Pathway Gene RS ID Most Significant Results in Three Genetic Models: Odds Ratio (99% Confidence Interval) and P-Value
Minimum P Value
Whole Case-Control Dataset COPD Patients without Lung Cancer and Healthy Control Dataset COPD Patients with Lung Cancer and Healthy Control Dataset
GSH ABCC1 rs16967755 1.51(1.08 -2.10) 1.50(0.95 -2.38) 1.45(1.00 -2.10) 1.60×10-3
1.60×10-3 2.36×10-2 1.01×10-2
GSH ABCC4 rs7324283 1.90(1.07 -3.37) 2.40(1.17 -4.91) 1.58(0.83 -3.04) 1.60×10-3
3.93×10-3 1.60×10-3 6.88×10-2
GSH GCLC rs12524550 2.42(1.11 -5.28) 2.60(0.92 -7.34) 2.11(0.91 -4.90) 3.54×10-3
3.54×10-3 1.79×10-2 2.28×10-2
GSH GCLC rs2100375 0.75(0.58 -.97) 0.33(0.10 -1.04) 0.78(0.58 -1.03) 3.66×10-3
3.66×10-3 1.25×10-2 2.29×10-2
GSH ABCC3 rs8075406 0.70(0.50 -.97) 0.65(0.41 -1.02) 0.70(0.48 -1.01) 4.88×10-3
4.88×10-3 1.45×10-2 1.17×10-2
GSH ABCC4 rs1729786 1.61(1.01 -2.56) 1.43(1.03 -2.00) 1.59(0.94 -2.70) 5.67×10-3
8.91×10-3 5.67×10-3 2.29×10-2
GSH GCLC rs542914 0.78(0.62 -.99) 0.80(0.58 -1.11) 0.78(0.60 -1.02) 6.26×10-3
6.26×10-3 7.70×10-2 1.68×10-2
GSH GCLC rs4712035 1.37(1.01 -1.86) 1.38(0.86 -2.21) 1.36(0.97 -1.90) 7.01×10-3
7.01×10-3 8.41×10-2 1.76×10-2
GSH GSTP1 rs1138272 0.64(0.41 -1.00) 0.76(0.42 -1.36) 0.60(0.36 -.99) 8.19×10-3
9.80×10-3 2.20×10-1 8.19×10-3
GSH ABCC2 rs717620 1.28(0.96 -1.72) 1.87(0.57 -6.12) 1.39(1.01 -1.94) 8.80×10-3
2.77×10-2 1.74×10-1 8.80×10-3
GSH GSS rs6088659 0.29(0.09 -.99) 0.39(0.07 -2.06) 0.23(0.05 -1.01) 9.22×10-3
9.22×10-3 1.47×10-1 1.06×10-2
GSH ABCC2 rs2756109 0.79(0.62 -1.00) 0.69(0.43 -1.11) 0.80(0.61 -1.04) 9.34×10-3
9.34×10-3 4.35×10-2 2.55×10-2
GSH ABCC1 rs215100 0.65(0.38 -1.12) 0.65(0.30 -1.41) 0.76(0.58 -1.00) 9.69×10-3
3.99×10-2 1.52×10-1 9.69×10-3
DNA MSH3 rs12513549 4.04(0.72 -22.80) 8.68(1.36 -55.26) 1.35(0.89 -2.05) 2.63×10-3
3.75×10-2 2.63×10-3 6.64×10-2
DNA XPA rs1800975 0.85(0.62 -1.18) 0.60(0.38 -.94) 0.99(0.69 -1.42) 3.33×10-3
2.05×10-1 3.33×10-3 9.26×10-1
DNA PARP rs11842915 1.26(0.93 -1.69) 1.53(1.02 -2.28) 1.14(0.77 -1.68) 6.43×10-3
4.79×10-2 6.43×10-3 3.81×10-1
DNA ×10RCC2 rs3916874 1.31(1.01 -1.70) 1.56(1.00 -2.46) 1.28(0.96 -1.71) 7.40×10-3
7.40×10-3 1.08×10-2 2.63×10-2
DNA MSH3 rs33013 0.72(0.52 -1.00) 0.80(0.51 -1.26) 0.69(0.48 -.99) 8.42×10-3
1.01×10-2 2.11×10-1 8.42×10-3
DNA MSH3 rs12522132 2.17(0.58 -8.09) 4.49(1.03 -19.52) 1.22(0.83 -1.82) 8.54×10-3
1.31×10-1 8.54×10-3 1.86×10-1
DNA MSH3 rs2897298 2.28(0.62 -8.32) 4.48(1.03 -19.47) 1.21(0.81 -1.79) 8.58×10-3
1.03×10-1 8.58×10-3 2.17×10-1
Inflammation PTGS2 rs689470 2.26(0.96 -5.36) 3.02(1.05 -8.71) 1.96(0.72 -5.32) 7.03×10-3
1.47×10-2 7.03×10-3 8.41×10-2